Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular mechanisms involved in Interleukin-6-induced epithelial-mesenchymal transition in MCF-7 breast cancer cells

Date

19 Dec 2015

Session

Poster presentation 1

Presenters

Ya-Fen Hsu

Citation

Annals of Oncology (2015) 26 (suppl_9): 1-7. 10.1093/annonc/mdv517

Authors

Y. Hsu1, M. Hsu2

Author affiliations

  • 1 Department Of Surgery, Landseed Hosipital, 32624 - Taoyuan/TW
  • 2 Department Of Pharmacology, Taipei Medical Unversity, 11031 - Taipei/TW
More

Resources

Abstract 1074

Aim/Background

Breast cancer is one of the leading causes of cancer-related death in women worldwide. The difficulties in breast cancer treatment are attributed to the highly metastatic ability of breast cancer cells. Serum interleukin-6 (IL-6) level increases with tumor grade of breast cancer, and elevated serum IL-6 correlates with poor breast cancer patient survival. In addition, the aberrant activation of epithelial-mesenchymal transition (EMT) has been implicated in the enhanced tumor metastasis. Recently, IL-6 has been shown to induce EMT in breast cancer cells with an epithelial phenotype. However, the underlying mechanisms by which IL-6 induces EMT remain to be fully defined.

Methods

In this study, we explored the underlying mechanisms of IL-6 in inducing EMT in MCF-7 breast cancer cells.

Results

Treatment of MCF-7 cells with IL-6 results in EMT, as evidenced by induction of the mesenchymal markers twist and snail and repression of the epithelial marker E-cadherin. IL-6 also increased cell motility in MCF-7 cells. These actions were associated with Src and FAK activation, as well as the phosphorylation of STAT3, p65 and C/EBPß. Src-FAK signaling blockade reduced IL-6's actions on the phosphorylation of STAT3, p65 and C/EBPß and subsequent EMT. In addition, STAT3 knockdown by STAT3 siRNA suppressed IL-6-induced EMT. Furthermore, IL-6 caused increases in STAT3, p65 and C/EBPß binding to the twist promoter region in MCF-7 cells.

Conclusions

In conclusion, we demonstrated in this study that IL-6 may activate Src-FAK-STAT3 signaling cascade, leading to EMT and subsequent breast cancer metastasis. Transcription factors p65 and C/EBPß may also contribute to IL-6-induced EMT in MCF-7 cells.

Clinical trial identification

None

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings